Exercise and inflammatory bowel disease

Canadian Journal of Gastroenterology

Volumn 22, Issue 5, 2008, Pages 497-504

  Narula, Neeraj ^a   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bone mineral density; Crohn's disease; Exercise; Inflammatory bowel diseases; Pouchitis; Ulcerative colitis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; RISEDRONIC ACID; TACROLIMUS; VITAMIN D;

ANKYLOSING SPONDYLITIS; BODY MASS; BONE DENSITY; CLINICAL TRIAL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; ENVIRONMENTAL FACTOR; EXERCISE; FRACTURE; GASTROINTESTINAL SURGERY; GASTROINTESTINAL SYMPTOM; GENETIC RISK; HUMAN; IMMUNE RESPONSE; LIFE STRESS; MUSCLE FUNCTION; MUSCLE TRAINING; OBESITY; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PHYSICAL MEDICINE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; REVIEW; RISK FACTOR; STRESS MANAGEMENT; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

COLITIS, ULCERATIVE; CROHN DISEASE; EXERCISE; HUMANS;

EID: 46749118826     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/785953     Document Type: Review

References (67)

1. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: A population-based study. Am J Gastroenterol 2006;101:1559-68. (Erratum in 2006;101:1945).
2. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57.
3. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004;10:286-99.
4. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc Nutr Soc 2007;66:307-15.
5. Ball E. Exercise guidelines for patients with inflammatory bowel disease. Gastroenterol Nurs 1998;21:108-11.
6. Peters HP, De Vries WR, Vanberge-Henegouwen GF, Akkermans LM. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut 2001;48:435-9.
7. Paffenbarger RS Jr, Hyde RT, Wing AL, Steinmetz CH. A natural history of athleticism and cardiovascular health. JAMA 1984;252:491-5.
8. Ellingson T, Conn VS. Exercise and quality of life in elderly individuals. J Gerontol Nuts 2000;26:17-25.
9. PalUska SA, Schwenk TL. Physical activity and mental health: Current concepts. Sports Med 2000;29:167-80.
10. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 1996;7:253-63.
11. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327-34.
12. Sanchez LD, Tracy JA, Berkoff D, Pedrosa I. Ischemic colitis in marathon runners: A case-based review. J Emerg Med 2006;30:321-6.
13. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990;31:1037-40.
14. Persson P-G, Leijonmarck CE, Bernell O, Hellers G, Ahlbom A. Risk indicators for inflammatory bowel disease. Int J Epidemiol 1993;22:268-72.
15. Boggild H, Tuchsen F, Orhede E. Occupation, employment status and chronic inflammatory bowel disease in Denmark. Int J Epidemiol 1996;25:630-7.
16. Klein I, Reif S, Farbstein H, Halak A, Gilat T. Preillness non dietary factors and habits in inflammatory bowel disease. Ital J Gastroenterol Hepatol 1998;30:247-51.
17. Cucino C, Sonnenberg A. Occupational mortality from inflammatory bowel disease in the United States 1991-1996. Am J Gastroenterol 2001;96:1101-5.
18. Marri SR, Buchman AL. The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis 2005;11:171-7.
19. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: A co-twin control study of a Swedish-Danish twin population, Inflamm Bowel Dis 2006;12:925-33.
20. Moeller JL. Inflammatory bowel disease arthropathy. Curr Sports Med Rep 2005;4:105-7.
21. Ireland J. Pisani out indefinitely with ulcerative colitis. Edmonton Journal (September 5, 2007). (Version current at March 27, 2008).
22. Benirschke R, Yorkey M. Alive and Kicking, 2nd edn. San Diego: Rolf Benirschke Enterprises Inc, 1999.
23. Taylor R. Tight End Turnstile 1979-2003. (Version current at March 27, 2008).
24. Elsenbruch S, Langhorst J, Popkirowa K, et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005;74:277-87.
25. Gupta N, Khera S, Vempati RP, Sharma R, Bijlani RL. Effect of yoga based lifestyle intervention on state and trait anxiety. Indian J Physiol Pharmacol 2006;50:41-7.
26. Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN. The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol 1999;94:697-703.
27. Ng V, Millard W, Lebrun C, Howard J. Low-intensity exercise improves quality of life in patients with Crohn's disease. Clin J Sport Med 2007;17:384-8.
28. D'Inca R, Varnier M, Mestriner C, Martines D, D'Odorico, A, Sturniolo GC. Effect of moderate exercise on Crohn's disease patients in remission. Ital J Gastroenterol Hepatol 1999;31:205-10.
29. O'Sullivan M, Nic Suibhne T, Shuhaibar M, O'Morain C. Lifestyle patterns in people with quiescent Crohn's disease: A role for health promotion? Digestive Disease Week 2007. Washington, May 19 to 24, 2007. (Abst)
30. Brevinge H, Berglund B, Bosaeus I, Tolli J, Nordgren S, Lundholm K. Exercise capacity in patients undergoing proctocolectomy and small bowel resection for Crohn's disease. Br J Surg 1995;82:1040-5.
31. Wiroth JB, Filippi J, Schneider SM, et al. Muscle performance in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 2005;11:296-303.
32. Izquierdo M, Ibanez J, Gorostiaga E, et al. Maximal strength and power characteristics in isometric and dynamic actions of the upper and lower extremities in middle-aged and older men. Acta Physiol Scand 1999;167:57-68.
33. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study. Am J Gastroenterol 2001;96:1116-22.
34. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002;61(Suppl 3):iii40-50.
35. Uhrin Z, Kuzis S, Ward MM. Exercise and changes in health status in patients with ankylosing spondylitis. Arch Intern Med 2000;160:2969-75.
36. Ince G, Sarpel T, Durgun B, Erdogan S. Effects of a multimodal exercise program for people with ankylosing spondylitis. Phys Ther 2006;86:924-35. (Erratum in 2006;86:1452).
37. Lim HJ, Moon YI, Lee MS. Effects of home-based daily exercise therapy on joint mobility, daily activity, pain, and depression in patients with ankylosing spondylitis. Rheumatol Int 2005;25:225-9.
38. Fernandez-de-Las-Penas C, Atonso-Blanco C, Alguacil-Diego IM, Miangolarra-Page JC. One-year follow-up of two exercise interventions for the management of patients with ankylosing spondytitis: A randomized controlled trial. Am J Phys Med Rehabil 2006;85:559-67.
39. Siffledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's: Risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004;10:220-8.
40. van Hogezand RA, Harady NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl 2006;59-64.
41. Robinson RJ. Crohn's disease, exercise and bone density. Res Clin Forums 2000;22:171-5.
42. American Gastroenterological Association. American Gastroenterological Association Medical Position Statement: Guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:791-4.
43. Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol 2006;12:5680-6.
44. Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006;23:1007-16.
45. Sylvester FA, Wyzga N, Hyams JS, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:42-50.
46. von Scheven E, Gordon CM, Wypij D, Wertz M, Gallagher KT, Bachrach L. Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: A Glaser Pediatric Research Network study. J Pediatr Endocrinol Metab 2006;19:821-30.
47. Paganelli M, Albanese C, Borrelli O, et al. Inflammation is the main determinant of tow bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2007;13:416-23.
48. Grey A. Emerging pharmacologic therapies for osteoporosis. Expert Opin Emerg Drugs 2007;12:493-508.
49. Henderson S, Hoffman N, Prince R. A double-blind ptacebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. Am J Gastroenterol 2006;101:119-23.
50. Doggrell SA. Present and future pharmacotherapy for osteoporosis. Drugs Today (Barc) 2003;39:633-57.
51. Lee N, Radford-Smith G, Taaffe DR. Bone loss in Crohn's disease: Exercise as a potential countermeasure. Inflamm Bowel Dis 2005;11:1108-18.
52. Vainionpaa A, Korpelainen R, Leppaluoto J, Jamsa T. Effects of high-impact exercise on bone mineral density: A randomized controlled trial in premenopausal women. Osteoporos Int 2005;16:191-7.
53. Robinson RJ, Krzywicki T, Almond L, et al. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: A randomized controlled trial. Gastroenterology 1998;115:36-41.
54. Rakshit RC, Almond L, al-Azzawi F, et al. Exercise and bone mineral density in Crohn's disease. Gastroenterology 2006;30:A653. (Abst)
55. Mauro M, Armstrong D. Evaluation of densitometric bone-muscle relationships in Crohn's disease. Bone 2007;40:1610-4.
56. Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;49:469-74.
57. Tanaka M, Kazuma K. Ulcerative colitis: Factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005;14:65-73.
58. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909-18.
59. DiLorenzo TM, Bargman EP, Stucky-Ropp R, Brassington GS, Frensch PA, LaFontaine T. Long-term effects of aerobic exercise on psychological outcomes. Prev Med 1999;28:75-85.
60. Brolinson PG, Elliott D. Exercise and the immune system. Clin Sports Med 2007;26:311-9.
61. Gleeson M. Immune function in sport and exercise. J Appl Physiol 2007;103:693-9.
62. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008;7:34-42.
63. Kugathasan S, Nebel J, Skelton JA, et al; Wisconsin Pediatric Inflammatory Bowel Disease Alliance; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007;151:523-7.
64. Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002;21:51-7.
65. Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 2006;4:482-8.
66. Efron JE, Uriburu JP, Wexner SD, et al. Restorative proctocolectomy with iteal pouch anal anastomosis in obese patients. Obes Surg 2001;11:246-51.
67. Lascano CA, Soto F, Carrodeguas L, Szomstein S, Rosenthal RJ, Wexner SD. Management of ulcerative colitis in the morbidly obese patient: Is bariatric surgery indicated? Obes Surg 2006;16:783-6.